News & Events

Contacts:



 

National Institutes of Health (NIH) Clinical Center Selects QuadraMed AcuityPlus Solution



Reston, VA — July 22, 2009 —

RESTON, Va., Jul 22, 2009 (BUSINESS WIRE) -- QuadraMed (NASDAQ:QDHC) today announced that the National Institutes of Health Clinical Center (NIH Clinical Center) in Bethesda, Md. selected QuadraMed AcuityPlusTM productivity, benchmarking and outcomes system to optimize its nursing resources enterprise-wide.

NIH's 234-bed clinical research hospital purchased the AcuityPlus platform, which includes inpatient, ambulatory and mental health methodologies, outcomes module, and import and export features, to help ensure interoperability with existing ADT and staff scheduling systems. The solution suite provides data analysis and monitoring to determine efficient staffing and budget projection and management, as well as a reporting module for true acuity-adjusted benchmarking.

NIH Clinical Center had been a QuadraMed MPI and HIM consulting client from 2005 through 2007. "This expansion of our NIH Clinical Center relationship reflects our dedication to delivering demonstrable clinical and operational efficiencies while improving patient safety and care," said James E. Peebles, interim president and CEO of QuadraMed. "This deployment is particularly significant because it marks the first time that AcuityPlus has been adopted by a federal government healthcare system. We look forward to strengthening and expanding this relationship in the coming years."

About National Institutes of Health Clinical Center

The Clinical Center at the National Institutes of Health (NIH) is the nation's largest hospital devoted entirely to clinical research. It is a national resource that makes it possible to rapidly translate scientific observations and laboratory discoveries into new approaches for diagnosing, treating, and preventing disease. Through clinical research, physician-investigators translate laboratory discoveries into better treatments, therapies and interventions to improve the nation's health. For more information, visit http://clinicalcenter.nih.gov.

About QuadraMed Corporation

QuadraMed Corporation advances the success of healthcare organizations through IT solutions that leverage quality care into positive financial outcomes. QuadraMed provides real world solutions that help healthcare professionals deliver outstanding patient care efficiently and cost effectively. Behind the company's products and services is a staff of 600 professionals whose experience and dedication have earned QuadraMed the trust and loyalty of clients at over 2,000 healthcare provider facilities. For more information about QuadraMed, visit http://www.quadramed.com.

Cautionary Statement on Risks Associated with QuadraMed Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 by QuadraMed that are subject to risks and uncertainties. The words "believe," "expect," "anticipate," "intend," "plan," "estimate," "may," "should," "could," and similar expressions are intended to identify such statements. Forward-looking statements are not guarantees of future performance and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement except as required by law. QuadraMed advises investors that it discusses risk factors and uncertainties that could cause QuadraMed's actual results to differ from forward-looking statements in its periodic reports filed with the Securities and Exchange Commission ("SEC"). QuadraMed's SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC's EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833).

QuadraMed is a registered trademark of QuadraMed Corporation. All other trademarks are the property of their respective holders.

No endorsement of any organization, product or service mentioned in this article is intended by the National Institutes of Health or its employees or should be inferred.

SOURCE: QuadraMed Corporation

###